KIMBERLY GONZALEZ: Open Payments
NPI 1326673542 · SANTA ANA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$282 in 11 payments from 6 companies in 2025. Trend: 2023 $84 · 2024 $256 · 2025 $282
Food & beverage: $282
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 3 | $105 |
| Novo Nordisk Inc | 2 | $52 |
| Amgen Inc. | 2 | $42 |
| Lilly USA, LLC | 2 | $39 |
| Xeris Pharmaceuticals, Inc. | 1 | $25 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
Products named: Omnipod, OTEZLA, MOUNJARO, Wegovy, RECORLEV, t:slim X2 Insulin Pump with Control-IQ, Ozempic.
Industry payments across CA — which companies pay providers there.
